The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
Blow-Fill-Seal (BFS) Packaging Services in Healthcare Market– Insights Blow-fill-seal (BFS) is a manufacturing technique used for packaging of injectable solutions, antibiotics, ophthalmological drops, ... Read more
Global Custom Recombinant Protein Production Services Market – Market Insights Custom recombinant protein production plays a major role in advanced healthcare and is the most efficient technique used in... Read more
Peptide Receptor Radionuclide Therapy (PRRT) Market Insights Peptide receptor radionuclide therapy (PRRT) is considered as targeted radionuclide therapy, as it provides radiation to destroy cancer cells via... Read more
Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Insights Human papillomavirus (HPV) and Cytomegalovirus (CMV) are viral pathogens. HPV is a different virus than HIV (Human Immunodefic... Read more
Global Asthma Therapeutics Market Insights Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the mo... Read more
Stomach Cancer Drugs Market – Insights Stomach cancer, is a buildup of abnormal cells that form a mass in part of the stomach. Symptoms of stomach cancer include fatigue, feeling bloated after eating, s... Read more
Infertility Drugs Market – Insights Infertility is a global health issue as its affects both men and women. Infertility in females occur due to increasing age, polycystic ovarian syndrome (PCOS), obesit... Read more
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market – Insights Chronic obstructive pulmonary disease (COPD) involves lung inflammation, causing obstruction of airflow from the lungs. It... Read more
Autism Spectrum Disorder Therapeutics Market – Insights Autism Spectrum Disorder (ASD) is a neurodegenerative disorder, which is associated and often overlaps with other conditions such as epilepsy, fre... Read more
India Immune-Oncology Drugs Market – Insights Immuno-oncology products come under biological therapeutic products. Immuno-oncology drugs are primarily used in therapeutic applications for treatment of v... Read more
DNA Repair Drugs Market – Breakthrough for Cancer Patients DNA repair drugs are used in repairing damaged DNA and for treating cancers. DNA damage results in genetic disorders, however the human body ha... Read more
Heparin Market – Insights Heparin is used to prevent or treat certain blood vessel, heart, and lung conditions. It is also used in blood transfusion, blood samplings during prophylaxis treatment, and fo... Read more
Global Beta Glucan Based Products Market – Global Industry Insights Beta glucan is a valuable dietary ?ber present in cereal crops, especially in barley, oat, and some mushrooms. According to the EC Nut... Read more
Global Hepatic Encephalopathy Market – Global Industry Insights Hepatic encephalopathy (HE) is a neuropsychiatric complication commonly associated with the liver disease: cirrhosis. The inability of the... Read more
P2X7 Receptor Antagonist Market Insights The P2X7 receptor is an ATP-gated, non-selective cation channel that has been linked to a number of inflammatory diseases. Activation of the P2X7 receptor by elevated ... Read more
Global Osteoarthritis Drugs Market – Effective Osteoarthritis Treatment Osteoarthritis, also known as degenerative joint disease, is the most common form of arthritis. It can affect various joints in th... Read more
Cordyceps Sinensis and Militaris Extract Market Insights Cordyceps Sinensis and C. militaris is a combination of parasitic fungus species and dead caterpillars that offer several potential health applications... Read more
Primary Biliary Cholangitis Treatment Market Insights Primary biliary cirrhosis, also known as primary biliary cholangitis is a chronic liver disease, which causes liver inflammation, fibrosis, and obstructio... Read more